PATENT CLAIM ANALYSIS

Application Number: 16067732
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "574000"]

Abstract:
Provided are compositions for non-stressful activation of cellular, tissues specific and systemic immune defenses in the treatment of bacterial, virus, fungal or parasite (protozoa) infections and infections/inflammation arising from toxins or toxic agents, and related diseases and/or disorders. In particular, pharmaceutical compositions, dietary supplements and nutritive compositions comprising one or more compounds selected from the group consisting of D-glyceric acid, DL-glyceric acid and salts and esters thereof for use in treating, preventing or alleviating a communicable and/or infectious disease or disorder and/or related inflammation are described.

Claim (Index 22):
The method according to  claim 13 , wherein the composition is in a form of a solution, syrup, powder, ointment, mixture, capsule, tablet, or an inhalable preparation, or wherein the composition further comprises a pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 1.44118
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14917764', '13095622', '11506611', '12648155', '14946732']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7503471478296639
- 35 USC 102 Novelty (BERT): 0.5380192775809414
- Combined Prediction Score: 0.7291143608047916
- Mean Citation Score: 217.28577600000003
- Max Citation Score: 371.38538
- Similarity Product: 280.79357223563204

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test